{"entity":{"id":"nct06915246","kind":"trial","name":"A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma","aka":[],"tldr":"A phase 2 trial of Carmustine in hodgkin lymphoma and non-hodgkin lymphoma, run by VIVUS LLC, now recruiting.","summary":"A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma is a phase 2 interventional study registered as NCT06915246 by VIVUS LLC, with 49 participants planned, started 2025-03-12 and due to reach its primary completion in 2027-03-31. Interventions recorded: VI-0609, BiCNU. Conditions listed: Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06915246","url":"https://clinicaltrials.gov/study/NCT06915246"}],"tags":["ctgov-ingest"],"related":[],"cancers":["hodgkin-lymphoma","non-hodgkin-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":["carmustine"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06915246","phase":"2","setting":"A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)","sponsor":"VIVUS LLC","enrolled":49,"outcomes":[]},"route":"/trials/nct06915246/","neighbours":{"cancer":[{"id":"hodgkin-lymphoma","kind":"cancer","name":"Hodgkin lymphoma","route":"/cancers/hodgkin-lymphoma/"},{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"drug":[{"id":"carmustine","kind":"drug","name":"Carmustine","route":"/drugs/carmustine/"}]}}